Rowley Law PLLC is investigating potential securities law violations by Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) and its board of directors concerning the proposed acquisition of the company by members of the Company’s senior management and other investors. Stockholders will receive $19.75 in cash for each share of Cellular Biomedicine Group stock that they hold. The transaction is expected to close in the fourth quarter of 2020.
If you are a stockholder of Cellular Biomedicine Group, Inc. and are interested in obtaining additional information regarding this investigation, please fill in the contact form on this page. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Request Information
The submission of this form does not create an attorney-client relationship.